home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

The Best Muscle Gene Therapy Of All?

  March, 8 2005 9:00
your information resource in human molecular genetics
In a head-to-head comparison of several gene therapy delivery approaches, researchers have identified the optimal means of delivering therapeutic genes to muscle tissues with a single intravenous injection -- an approach that may prove useful for treating heart disease and muscular dystrophies.

In the March issue of Nature Biotechnology, Xiao Xiao and colleagues identify a virus that overcomes the obstacle of delivering genes across the blood vessel barrier to heart and skeletal muscles in animals. A comparative study of many different types of modified adeno-associated virus (AAV) revealed a subtype - AAV8, particularly adept at delivering genes to the skeletal and cardiac muscles of mice and hamsters. Previous attempts to systemically deliver genes into animals using AAV required the use of drugs to help them cross the blood vessel walls and gain access to muscle. One subtype, AAV8, however, proved to be particularly effective on its own.

To validate their findings, the authors then used AAV8 to deliver a repaired version of the delta-sarcoglycan gene into hamsters with a gene defect associated with a type of muscular dystrophy and heart failure. They show that AAV8 was able to deliver the delta-sarcoglycan gene to the hamsters' tissues, resulting in the correction of pathological signs of dystrophic heart and skeletal muscles.

Author Contact:

Xiao Xiao (University of Pittsburgh, PA, USA)
Tel: +1 412 648 9487
E-mail: xiaox@pitt.edu

Also available online.

(C) Nature Biotechnology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.